These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 19016004

  • 1. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO.
    Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
    [Abstract] [Full Text] [Related]

  • 2. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H.
    J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
    [Abstract] [Full Text] [Related]

  • 3. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
    Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O.
    Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
    [Abstract] [Full Text] [Related]

  • 4. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 May; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 6. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
    Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO.
    Endocrine; 2009 Feb; 35(1):75-80. PubMed ID: 18958631
    [Abstract] [Full Text] [Related]

  • 7. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M.
    J Endocrinol Invest; 2008 Jun; 31(6):537-41. PubMed ID: 18591887
    [Abstract] [Full Text] [Related]

  • 8. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [Abstract] [Full Text] [Related]

  • 9. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.
    Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu İ, Ersoz HO.
    Endocrine; 2009 Dec; 36(3):473-8. PubMed ID: 19859836
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 11. Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I.
    Wildbrett J, Hanefeld M, Fücker K, Pinzer T, Bergmann S, Siegert G, Breidert M.
    Exp Clin Endocrinol Diabetes; 1997 Sep; 105(6):331-5. PubMed ID: 9439928
    [Abstract] [Full Text] [Related]

  • 12. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C, Ersoz HO, Karti SS, Ukinç K, Hacihasanoglu A, Değer O, Telatar M.
    J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
    [Abstract] [Full Text] [Related]

  • 13. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism.
    Alioğlu B, Kılıç N, Şimşek E, Dallar Y.
    J Clin Res Pediatr Endocrinol; 2012 Sep; 4(3):146-50. PubMed ID: 22985614
    [Abstract] [Full Text] [Related]

  • 14. Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma.
    Erem C, Kocak M, Nuhoglu I, Yılmaz M, Ucuncu O.
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):502-7. PubMed ID: 20039901
    [Abstract] [Full Text] [Related]

  • 15. Coagulation parameters and platelet function analysis in patients with acromegaly.
    Colak A, Yılmaz H, Temel Y, Demirpence M, Simsek N, Karademirci İ, Bozkurt U, Yasar E.
    J Endocrinol Invest; 2016 Jan; 39(1):97-101. PubMed ID: 26048595
    [Abstract] [Full Text] [Related]

  • 16. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P, Kotuličová D, Staško J, Kubisz P.
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
    [Abstract] [Full Text] [Related]

  • 17. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D, Bara L, Basdevant A, Samama MM.
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
    [Abstract] [Full Text] [Related]

  • 18. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH.
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [Abstract] [Full Text] [Related]

  • 19. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
    Jönsson Rylander AC, Lindgren A, Deinum J, Bergström GM, Böttcher G, Kalies I, Wåhlander K.
    J Thromb Haemost; 2017 Apr; 15(4):758-769. PubMed ID: 28135035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.